Development of LILRB4 biparatopic synthetic T-cell receptor and antigen receptor (STAR)-T cells for the treatment of acute myeloid leukemia (AML)

YTS104 - BriSTAR Immunotech, Beijing Qingyi Taike Pharma

https://www.abstractsonline.com/pp8/#!/10828/presentation/3051

Wei Rui; Lei Lei; Zezhong Zhang; Chunyan Wu; Yu Xia; Yingying Liu; Xiaojing Pang; Ruifang Du; Lan Wang; Dengyue Sheng; Jing Guo; Yanyan Zhang; Xueqiang Zhao; James Pan

Mar 14, 2023